Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 11, 2009, Pages 1485-1492

  Xiang, Li ^a   Dongkai, Wang ^a   Jing, Zhang ^a   Weisan, Pan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Docetaxel; Hot high pressure homogenisation; Nanostructured lipid carriers; Pharmacokinetics; Tissue distribution; X ray powder diffraction

Indexed keywords

CRYOPROTECTIVE AGENT; DOCETAXEL; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CRYOPROTECTION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; FREEZE DRYING; LUNG CANCER; MALE; MEAN RESIDENCE TIME; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RAT; TISSUE DISTRIBUTION; X RAY POWDER DIFFRACTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FREEZE DRYING; LIPIDS; LUNG; MALE; NANOSTRUCTURES; ORGAN SPECIFICITY; RATS; RATS, WISTAR; TAXOIDS;

EID: 75749121074     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp/61.11.0007     Document Type: Article

References (21)

1. Zhang XL. Research progression of docetaxel in clinical application. Prog Pharm Sci 2006; 30: 516-520.
2. Baker J et al. Docetaxel-related side effects and their management. Eur J Oncol Nurs 2009; 13: 49-59.
3. Müller RH et al. Cytotoxicity of magnetite loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles (SLN). Int J Pharm 1996; 138: 85-94.
4. Yang SC et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 1999; 59: 299-307.
5. Wissing SA et al. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004; 56: 1257-1272.
6. Müller RH et al. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002; 242: 121-128.
7. Hu FQ et al. Preparation and characterization of stearic acid nanostructured lipid carrier by solvent diffusion method in an aqueous system. Colloids Surf B: Biointerfaces 2005; 45: 167-173.
8. Zhang CX et al. Preparation and characterization of docetaxel liposomes. Chinese Journal of New Drugs 2007; 16: 780-783.
9. Jenning V et al. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000; 199: 167-177.
10. Souto EB et al. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278: 71-77.
11. Kim BD et al. Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur J Pharm Sci 2005; 24: 199-205.
12. Chen DB et al. In vitro and in vivo study of two kinds of long-circulating solid lipid nanoparticles containing paclitaxel. Acta Pharm Sinica 2002; 37: 54-58.
13. Molina MC et al. The stability of lyophilized lipid/DNA complexes during prolonged storage. J Pharm Sci 2004; 93: 2259-2273.
14. Allison SD et al. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta 2000; 1468: 127-138.
15. Hinrichs WLJ et al. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int J Pharm 2006; 311: 237-244.
16. Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001; 47: 165-196.
17. van Winden ECA. Freeze-drying of liposomes: theory and practice. Methods Enzymol 2003; 367: 99-110.
18. Talsma H et al. Stabilization of gene delivery systems by freeze-drying. Int J Pharm 1997; 157: 233-238.
19. Moghimi SM et al. Long circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001; 53: 283-318.
20. Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nano-particles after intravenous and intraduodenal administration. J Control Release 2005; 107: 215-228.
21. Mizushima Y et al. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann Rheum Dis 1982; 41: 263-267.